August 14th 2025
Irina Mazur spoke to Dermatology Times about the latest partnership, which aims to bridge the gap between clinical advice and patient behavior through personalized sun protection guidance.
Urea vehicle promotes tolerability of topical acne medication
May 1st 2004Washington, D.C. - A unique urea-containing vehicle appears to improve the tolerability of topical treatment with sodium sulfacetamide/sulfur in acne and rosacea patients with sensitive skin, according to the results of a randomized, double-blind, active comparator-controlled study presented by James J. Leyden, M.D., at the annual meeting of the American Academy of Dermatology.
FDA grants market approval for Hylaform
April 23rd 2004Inamed Corp. announced that the U.S. Food and Drug Administration has granted market approval for Hylaform, a hyaluronic acid-based dermal filler that is indicated for injection into the mid to deep dermis for correction of moderate to severe facial wrinkles and folds.
Sculptra gets backing of FDA panel to treat AIDS-related facial lipoatrophy
April 4th 2004Gaithersburg, Md. - The FDA General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee meeting on March 25 unanimously recommended approval of Sculptra for reconstructive purposes with lipoatrophy associated with HIV infection and treatment.
Vapocoolant spray pre-treatment eases pain of palmar injections
April 1st 2004Washington D.C. -- Cryoanesthesia using the refrigerant spray dichlorotetrafluoroethane (Freon 114; Frigiderm) safely and effectively reduces the pain of botulinum toxin type A (Botox) injections for palmar hyperhidrosis but does not interfere with the efficacy of that treatment for decreasing sweating, said Leslie S. Baumann, M.D., at the annual meeting of the American Academy of Dermatology here.
Dissecting cellulitis responds to Nd:YAG laser
April 1st 2004Washington D.C. - In a recent trial involving four patients with dissecting cellulitis, long-pulsed Nd:YAG (1,064 nm) laser treatments were shown to reduce pain, purulent drainage, and the need for systemic antibiotics. In addition, some patients' hair regrew without recurrence of the disease.
Filler frenzy is cause for consideration
April 1st 2004New York - As injectable filler options grow, so do their power to offer patients a second round of youthful looks. The market is expanding with fillers that offer various compositions, indications, durations of effect, and stages of FDA approval. The growing choices are cause for celebration and consideration.
Advantages of human-based collagen fillers complementary to other new options
April 1st 2004New York - Requiring no pretreatment allergy testing, human-based collagen fillers CosmoDerm and CosmoPlast are rapidly replacing bovine-based Zyderm and Zyplast, respectively, according to Brian M. Kinney, M.D.
Simple fat transfer approach avoids sharp needles
April 1st 2004New York - Imagine fat as a substance bundled into intact parcels that are a size and shape allowing for them to travel through a small cannula - both when harvested and injected. This is the key to transferring the permanent subcutaneous filler, Sydney R. Coleman, M.D. said.
Chemical combo promises reduced optical scattering
April 1st 2004Dallas - Pre-clinical research suggests a new compound can boost the efficacy of diagnostic and laser therapeutic applications. The chemical mixture appears to increase the transparency of normal human skin, thereby allowing a better, deeper and much greater penetration of light for diagnostic and therapeutic purposes.
Non-ablative radiofrequency finds niche in skin tightening
April 1st 2004Deer Valley, Utah -- Patients seeking long-lasting cosmetic improvement without a facelift have a new treatment modality - non-ablative radiofrequency (RF) - in which improvement continues for up to six months after a single treatment.
Vapocoolant spray pretreatment eases pain
April 1st 2004Washington D.C. - Cryoanesthesia using the refrigerant spray dichlorotetrafluoroethane (Freon 114; Frigiderm) safely and effectively reduces the pain of botulinum toxin type A (Botox) injections for palmar hyperhidrosis but does not interfere with the efficacy of that treatment for decreasing sweating, said Leslie S. Baumann, M.D., at the annual meeting of the American Academy of Dermatology here.
Nix cancer threat in organ transplant patients
April 1st 2004Washington - Extensive skin cancer can be a life-ruining or even lethal event for organ transplant recipients. Speaking at the annual meeting of the American Academy of Dermatology, Clark C. Otley, M.D., reviewed for his colleagues five lessons he learned, some times the hard way, to address this challenging problem.
Anti-TNF-? formula enhances wound healing
April 1st 2004Washington - Topical application of anti-tumor necrosis factor-? (TNF-?) monoclonal antibody (infliximab) produced dramatic improvement with wound closure in chronic, non-healing leg ulcers, said Markus Streit, M.D., department of dermatology, Inselspital, Bern, Switzerland.
1,450-nm laser treats facial acne rapidly
April 1st 2004Washington - The recently concluded American Academy of Dermatology conference witnessed the first published report documenting the safety and efficacy of the Smoothbeam laser treatment for inflammatory facial acne. Building on previous research that showed the 1,450-nm diode laser to be effective for treating inflammatory acne on the back, a team of researchers led by Paul M. Friedman, M.D., showed the same type of laser to be safe and effective for treating facial acne vulgaris.
Newer May Not Always Be Better
April 1st 2004About 15 years ago, while riding on a shuttle bus at the annual American Academy of Dermatology meeting, I overheard two elderly dermatologists discussing the state of dermatology, as they perceived it. One gentleman commented that he had not seen a single advance to rival the advent of tetracycline for acne, and that most of the new treatments did not work very well. At the time, I remember thinking that these practitioners were out of touch with all of the hot new therapies for skin disorders. Since that time, as I have been bombarded by myriad new and supposedly revolutionary "advances," I, too, am beginning to question whether we should equate the concept of "newness"
More office-based restrictions to come?
April 1st 2004National report - The continuing debate over the safety of office-based procedures ignited in Florida, where a 90-day moratorium on combined liposuction/ abdominoplasty procedures prompted new questions. Some surgeons wonder if such restrictions will become permanent - and if, in coming days, other states will follow suit or restrict other office-based procedures.
Q-switched combination laser provides option for treating hyperpigmentation
April 1st 2004Dallas - A new Q-switched combination 532/1,064 Nd:YAG laser provides physicians with an option for treating postsclerotherapy hyperpigmentation, according to a presentation scheduled for the annual meeting of American Society for Laser Medicine and Surgery.
Device delivers healing oxygen to wounds
April 1st 2004Washington - Preclinical study results indicate that topical oxygen therapy using an emulsion containing supersaturated oxygen may be a safe and effective method for enhancing healing of a variety of wounds, said Stephen C. Davis, at the annual meeting of the American Academy of Dermatology.
Pomegranate extract shows promise in boosting sun protection
April 1st 2004Maui, Hawaii - Some time in the not-too-distant future, people will ingest tablets for sun protection instead of slathering lotion over their bodies, according to Howard Murad, M.D. A dermatologist, pharmacist, and assistant clinical professor of dermatology at UCLA, Dr. Murad's personal quest is to develop that pill. He believes it may well contain pomegranate extract.